Kronos Bio Inc. (NASDAQ: KRON) Stock Information | RedChip

Kronos Bio Inc. (NASDAQ: KRON) Listen to this Section


$1.00
+0.0124 ( +1.26% ) 100.3K

Kronos Bio Inc is a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel cancer therapeutics designed to transform patient outcomes through a precision medicine plan by targeting dysregulated transcription. The company operates in one business segment, the development of biopharmaceutical products.

Market Data


Open


$1.00

Previous close


$0.99

Volume


100.3K

Market cap


$60.26M

Day range


$0.97 - $1.01

52 week range


$0.69 - $1.62

Insider Ownership Transactions

Total Amount Purchased: 1,540,416.00 | $ 1,540,416.00

Date Type Amount Purchased Purchaser
2024-07-01 Buy 410848.00 BISCHOFBERGER NORBERT W
2024-06-26 Sale -34000.00 Yang Taiyin
2024-06-26 Sale -34000.00 TANEN DAVID M
2024-06-26 Sale -34000.00 Belldegrun Arie
2024-06-26 Sale -34000.00 Kazam Joshua A
2024-06-26 Sale -34000.00 Blunt Roshawn A.
2024-06-26 Sale -34000.00 Stultz Katherine V
2024-06-26 Sale -34000.00 DANSEY ROGER D
2024-06-26 Sale -11333.00 Ridloff Elena
2024-06-12 Buy 1378901.00 BISCHOFBERGER NORBERT W

SEC Fillings


Form Type Description Pages Date
8-k 8K-related 15 Aug 08, 2024
10-q Quarterly Reports 68 Aug 08, 2024
4 Insider transactions 1 Jul 01, 2024
8-k 8K-related 13 Jun 27, 2024
4 Insider transactions 1 Jun 26, 2024
4 Insider transactions 1 Jun 26, 2024
4 Insider transactions 1 Jun 26, 2024
4 Insider transactions 1 Jun 26, 2024
4 Insider transactions 1 Jun 26, 2024
4 Insider transactions 1 Jun 26, 2024

Latest News


Terms and Agreement

Please agree to the terms to continue using the chat feature.